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GLOBAL STABILITY FOR A CLASS OF VIRUS MODELS WITH CTL
IMMUNE RESPONSE AND ANTIGENIC VARIATION
MAX O. SOUZA AND JORGE P. ZUBELLI
Abstract. We study the global stability of a class of models for in-vivo virus dynamics,
that take into account the CTL immune response and display antigenic variation. This class
includes a number of models that have been extensively used to model HIV dynamics. We
show that models in this class are globally asymptotically stable, under mild hypothesis, by
using appropriate Lyapunov functions. We also characterise the stable equilibrium points for
the entire biologically relevant parameter range. As a byproduct, we are able to determine
what is the diversity of the persistent strains.
1. Introduction
1.1. Models for in-vivo virus dynamics. A number of population dynamics models have
been proposed in order to describe the HIV in-vivo dynamics (Perelson & Nelson 1999, Nowak
& May 2000). Although these models have distinct features, since they attempt to incorporate
different aspects of the interaction between the virus and the immune system, many of them
share a common long-term behaviour, evolving towards an isolated equilibrium state (Nowak
& May 2000).
The basic model for the HIV in-vivo dynamics is given by a three-by-three, first-order
system of ordinary differential equations (ODEs)—(Nowak & Bangham 1996, Bonhoeffer,
et al. 1997, Nowak & May 2000):
(1)


x˙ = λ− dx− βxv,
y˙ = βxv − ay,
v˙ = ky − uv.
In this model, x denotes the uninfected cells, y the infected cells and v the free virus particles.
The average lifetime of an infected cell is 1/a, while the average lifetime of a virus particle is
1/u. The total number of virus particles produced by an infected cell is k/a. Healthy cells
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are infected at a rate βxv. New CD4+ T cells are produced, in the thymus, at a rate λ, and
die at a rate dx.
System (1) has two equilibrium points:
(1) The disease free equilibrium: x∗ = λ/d, y∗ = v∗ = 0;
(2) The endemic equilibrium: x∗ = au/βk, y∗ = (βλk−dau)/βak, v∗ = (βλk−dau)/βau.
The long term dynamics of System (1) can be entirely described in terms of the dimensionless
parameter
(2) R0 =
βλk
dau
,
also known as the basic reproductive ratio.
If R0 ≤ 1, the disease free equilibrium is a global attractor, and the infection cannot
persist. If R0 > 1, the endemic equilibrium becomes a global attractor, and the infections
persists indefinitely. This has been first observed numerically (Nowak & Bangham 1996,
Bonhoeffer et al. 1997, Nowak & May 2000). Mathematical proofs of these global stability
characteristics were given by Li & Muldowney (1995), using Hirsch’s theory of competitive
differential systems—see Smith (1995)—and, more recently by de Leenheer & Smith (2003)
and Korobeinikov (2004a) using a Lyapunov function approach.
Given the notable ability of the HIV to escape from immune response, there is interest
in studying models that account for a more detailed immune response as, for instance, the
role of cytotoxic T lymphocytes (CTLs). An example is the following four-by-four system of
ODEs (Nowak & Bangham 1996):
(3)


x˙ = λ− dx− βxv,
y˙ = βxv − ay − pyz,
v˙ = ky − uv,
z˙ = cyz − bz.
System (3) extends (1) by introducing the z variable, that denotes the CTL response. Infected
cells are killed at a rate pyz, while antigen stimulation produces CTL cells at a rate cyz. In
the absence of such a stimulation, CTL cells decay at a rate bz.
In the same vein, the high mutation rate of HIV naturally leads to the study of the interplay
between immune response and virus diversity for a number of different strains. The immune
response produces a selection pressure on these different strains of the virus, as discussed in
Nowak & Bangham (1996), when studying and numerically analysing a (3n+ 1)-by-(3n + 1)
first-order ODE system of the form:
(4)


x˙ = λ− dx− x
∑n
i=1 βivi,
y˙i = βixvi − aiyi − piyizi, i = 1, . . . , n,
v˙i = kiyi − uivi, i = 1, . . . , n,
z˙i = ciyizi − bizi, i = 1, . . . , n.
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System (4) is a slightly generalised form of the system studied by Nowak & Bangham (1996),
where the more restricted case ai = a, pi = p, ui = u, ci = c, and bi = b was addressed.
In all these models, there is the question as whether the long term dynamics approaches
an equilibrium or, more generally, an attractor, and how this might depend on the initial
condition. There is compelling numerical evidence—cf. (Nowak & Bangham 1996, Bonhoeffer
et al. 1997, Nowak & May 2000)—that Systems (3) and (4) are globally asymptotically stable.
However, no mathematical proof of this fact seems to be available. In System (4) there is also
the question of determining the antigenic diversity at the equilibrium.
In this work, we study the stability characteristics of the models given by (4) following
a Lyapunov approach. The Lyapunov functional used here has been used before by Kore-
beinikov & Wake (1999), in the global analysis of three-dimensional predator-prey systems,
and by Korobeinikov (2004a) and Korobeinikov (2004b) in the global analysis of various virus
models. More precisely, by using an appropriate linear combination of this Lyapunov func-
tional, we are able to show global asymptotic stability results for System (4), and hence to
(3).
The plan for this article goes as follows: We close this introductory section with further
biological background and motivations. In Section 2 we address some preliminary issues such
as choice of dimensionless variables and parameter reductions. We study the global stability
characteristics of model (3). In Section 3, we study the equilibria and global stability of
model (4) under the assumption of unique fitnesses of the strains. In this case, we determine
the possible equilibria of (4), and show than there are 2n−1(n+2) equilibrium points. We also
show that system is globally asymptotic stable, and we determine what is the global attractor
in the nonnegative orthant of R3n+1. As a byproduct, we characterise the attained diversity
and show that it is monotonically increasing with the strength of the immune response. Some
additional results for the case of nonunique fitnesses are also presented. We conclude in
Section 4 with a discussion of some of the implications of our results.
1.2. Biological Background and Motivation. The models studied by equation 4 have
many potential biological applications. Most notably, to within-host infections connected
to cytotoxic T lymphocytes with antigenic variation including, but not restricted to, HIV
infection. A better understanding of how the within-host HIV, interacts with immune cells
seems to be a key factor in the development of effective long-term therapies or possibly pre-
ventive vaccines for deadly diseases such as the acquired immunodeficiency syndrome (Nowak
& May 2000). Mathematical modeling of the underlying biological mechanisms and a good
understanding of the theoretical implications of such models is crucial in this process. In-
deed, it helps clarifying and testing assumptions, finding the smallest number of determining
factors to explain the biological phenomena, and analysing the experimental results (Asquith
& Bangham 2003). Furthermore, modeling has already impacted on research at molecu-
lar level (Nowak & May 2000) and important results have been obtained in modeling the
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virus dynamics for several infections, such as the HIV (Nowak & Bangham 1996, Perelson,
et al. 1993, Perelson, et al. 1996), hepatitis B (Marchuk, et al. 1991), hepatitis C (Neumann,
et al. 1998), and influenza (Bocharov & Romanyukha 1994).
In the particular case of the HIV infection, the dynamics of the within-host infection goes
as follows: First, the HIV enters a T cell. Being a retrovirus, once the HIV is inside the T cell,
it makes a DNA copy of its viral RNA. For this process it requires the reverse transcriptase
(RT) enzyme. The DNA of the virus is then inserted in the T-cell’s DNA. The latter in
turn will produce viral particles that can bud off the T cell to infect other ones. Before one
such viral particle leaves the infected cell, it must be equipped with protease, which is an
enzyme used to cleave a long protein chain. Without protease the virus particle is uncapable
of infecting other T cells.
One of the key characteristics of HIV is its extensive genetic variability. In fact, the HIV
seems to be changing continuously in the course of each infection and typically the virus
strain that initiates the patient’s infection differs from the one found a year ore more after
the infection. In this respect, the introduction of the different strains in the model is crucial
for it to be realistic.
In general terms, one can also say that Model (4) is similar in spirit to other models
such as food-chain models. The latter have attracted substantial interest by a number of
authors. See for example (Roy & Solimano 1986, Kooi & Hanegraaf 2001, Kooi, et al. 1998)
and references therein. However, the presence of more general quadratic terms or of logistic
terms on the right hand side of the different “strains” leads to a potentially richer dynamics
than the globally stable present in Model 4. See for example (Kooi & Hanegraaf 2001) for a
bifurcation analysis of certain food chain models.
2. Preliminaries
2.1. Parameter reduction. As already noticed in the introduction, a more restricted form
of (4) with a number of parameters being strain-independent has been studied by Nowak
& Bangham (1996). It turns out that some parameters in (4) can indeed be taken to be
strain-independent, as we now show.
We start by noting that if ki = 0, then vi decays exponentially with rate ui. Also, if pi = 0,
then the dynamics of zi does not impinges on the rest of the system. Thus, without loss of
generality, we can assume that ki, pi 6= 0, i = 1, . . . , n. In this case, following Pastore (2005),
we rescale the vis and βis. In addition, we also rescale the zis. More precisely, the change of
variables
(5) vi 7→
ki
k
vi, zi 7→
p
pi
zi and βi 7→
k
ki
βi
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takes (4) into
(6)


x˙ = λ− dx− x
∑n
i=1 βivi,
y˙i = βixvi − aiyi − pyizi, i = 1, . . . , n,
v˙i = kyi − uivi, i = 1, . . . , n,
z˙i = ciyizi − bizi, i = 1, . . . , n.
Intuitively, the change of variables (5) reflects that only the ratio βi/ki turns out to be
important, and that this can be already taken into account in the βis, provided we rescale
the vis. Moreover, it also shows that the precise value pi does not matter, as long as it is
nonzero.
2.2. Dimensionless constants. In Nowak & Bangham (1996), it was already observed that,
in addition to R0, the quantity cy
∗/b is also important in determining the global equilibria.
In a more precise fashion, Nowak & May (2000) define
RI = 1 +
βbk
cdu
,
which they term the basic reproductive ratio in the presence of immune response. However,
we follow Pastore (2005), and find more convenient to write
RI = 1 +
R0
I0
,
where
I0 =
cλ
ab
.
An alternative dimensionless constant is the CTL reproduction number given by
P0 =
I0(R0 − 1)
R0
.
Although only two constants among R0, I0 and P0 are independent, and are sufficient to
describe the regimes of (6), we have chosen to use both, three constants, as some conditions are
better characterised by P0, while much of the algebra in the Lyapunov functional derivatives
is better handled by expressing them in terms of R0 and I0. Thus, we shall use the strain
dependent constants:
(7) Ri0 =
βiλk
daiui
, Ii0 =
ciλ
aibi
and P i0 =
Ii0(R
i
0 − 1)
Ri0
.
2.3. Strain sets. In order to deal with plethora of equilibria that arises in System (6), we
shall now define some notation for some special set of strain indices. This will allows us to
deal conveniently with the combinatorial structure of the equilibria.
Without loss of generality, we shall assume that the strains are indexed by increasing order
of Ri0.
Let N = {1, 2, . . . , n}. Then, we define the set of the strong responders as
S = {i ∈ N |P i0 > 1}.
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Definition 1. We shall say that the set S of strong responders is consistent, if
S = {1, . . . ,m}, 1 ≤ m ≤ n.
This is certainly the cases, if the Ii0 satisfy I
i
0 ≥ I
i+1
0 . In particular, this holds if I
i
0 = I0 as
in the model studied by Nowak & Bangham (1996).
Given a set of indices I, we define
ρI0 =
∑
i∈I
Ri0
Ii0
.
Two important definitions are given below:
Definition 2. We shall say that I ⊂ S is an antigenic set, if
(8) Ri0 ≥ 1 + ρ
I
0 , i ∈ I
holds. In addition, if
(9) Ri0 ≤ 1 + ρ
I
0 , i 6∈ I.
also holds, we shall say that I is a stable antigenic set.
Notice that, if S 6= ∅, we have that I = {1} is an antigenic set. Let l be the largest integer
for which the set J = {1, . . . , l} is an antigenic set. Then we shall say that J is the maximal
antigenic set.
Two important facts about the maximal and stable antigenic sets are collected below:
Lemma 1. Assume that S 6= ∅, and that the strain basic reproductive numbers are distinct.
(1) If a stable antigenic set exists, then it is also the maximal antigenic set. In particular,
stable antigenic sets are unique.
(2) If N is the maximal antigenic set, then it is a stable antigenic set.
Proof. (1) Assume that I is a stable antigenic set and let il = max I. If 1 ≤ k < l, then
ik ∈ I. Indeed, by the increasing ordering and (8), we have that
Rik0 > R
il
0 ≥ 1 + ρ
I
0 .
But this contradicts (9), thus we must have ik ∈ I. Now assume that I
′ = {i1, . . . , il+1}
is also an antigenic set. Then we must have
Rl+10 ≥ 1 + ρ
I′
0 = 1 + ρ
I
0 +
Rl+10
I l+10
≥ 1 + ρI .
But this again contradicts (9) and, hence, that I is stable antigenic. Therefore, it is
maximal.
(2) This follows since, in this case, (9) cannot be violated.

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3. The model with antigenic variation
In this section we shall study the stability of of (6) in the non-negative orthant of R3n+1
which we shall denote by O. The positive orthant will be denoted by O+.
We observe that the planes zi = 0 and that O are positive invariant sets for (4), since the
field points inwards.
The equilibria and stability characteristics of (6) depend significantly whether the Ri0s are
distinct or not. In §3.1 and §3.2, we describe the equilibria and study their stability in the
case of unique fitnesses, i.e., we assume that if Ri0 = R
j
0, then i = j. In this case, with the
adopted order, we have that
Ri0 > R
i+1
0 , i = 1, . . . , n − 1.
Additional remarks when the fitnesses are not unique can be found in Section 3.3.
3.1. Equilibria. Let N = {1, 2, . . . , n}. It turns out that the equilibria of (4) can be con-
veniently indexed by (j,J ), where J ⊆ N , and either j = 0 or j 6∈ J . The corresponding
equilibrium point will be denoted by Xj,J .
Using this notation, we have
Lemma 2. System (6) has 2n−1(2 + n) equilibrium points which can be written as
Xj,J =
(
λ
d
Qxj,J ,
λ
a1
Qy1j,J , . . . ,
λ
an
Qynj,J ,
d
β1
Qv1j,J , . . . ,
d
βn
Qvnj,J ,
a1
p
Qz1j,J , . . . ,
an
p
Qznj,J
)
,
where
(1)
Qx0,∅ = 1, and Q
yi
0,∅
= Qvi
0,∅
= Qzi
0,∅
= 0.
(2) If j is such that 1 ≤ j ≤ n, then we have
Qxj,∅ =
1
Rj0
, Q
yj
j,∅
= 1−
1
Rj0
, Q
vj
j,∅
= Rj0 − 1 and Q
zj
j,∅
= 0.
and
Qyi
j,∅
= Qvi
j,∅
= Qzi
j,∅
= 0, i = 1, . . . , n, i 6= j.
(3) Given J ⊆ N , we have
Qx0,J =
1
1 + ρJ0
and
Qyi
0,J =
1
Ii0
, Qvi
0,J =
Ri0
Ii0
, Qzi
0,J =
Ri0
1 + ρJ0
− 1, i ∈ J ;
also
Qyi
0,J = Q
vi
0,J = Q
zi
0,J = 0, i 6∈ J .
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(4) Given a proper subset J ⊂ N , and 1 ≤ j′ ≤ n, j′ 6∈ J , we have that
Qxj′,J =
1
Rj
′
0
, Q
yj′
j′,J = 1−
1
Rj
′
0
−
ρJ0
Rj
′
0
, Q
vj′
j′,J = R
j′
0 − 1− ρ
J
0 , Q
zj′
j′,J = 0;
for i ∈ J , we have
Qyij′,J =
1
Ii0
, Qvij′,J =
Ri0
Ii0
, Qzij′,J =
Ri0
Rj
′
0
− 1.
For i 6∈ J , and i 6= j′, we have
Qyij′,J = Q
vi
j′,J = Q
zi
j′,J = 0.
Proof. The first equilibrium is trivial. The second type of equilibria is obtained by choosing
an index j such that zj = 0, but yj 6= 0. We can choose only one such j, since this determines
x. For the other indices i, we set yi = vi = zi = 0. The first equation then determines vj . The
third type is obtained by choosing a set J of indices, such that, for i ∈ J , we have zi 6= 0.
This readily determines yi and vi. For i 6∈ J , we have yi = vi = zi = 0. The first equation,
then, determines x. Finally, the last equilibria is found by having a set of indices J , as in the
equilibrium of the third type, and then choosing an index j′ 6∈ J as in the second equilibrium.
Again, only one such j′ can be chosen. 
3.2. Stability analysis. We are now ready to study the global stability of the equilibria
of System 6. Surprisingly, although there is a large number of equilibria, only four of them
will be globally stable. In what follows, unless otherwise is said, we shall assume that that
Ri0 > R
i+1
0 , for i = 1, . . . , n− 1, and that the set of strong responders is consistent.
Theorem 1. For system (6), defined on O, and with initial condition at its interior, there is
always a globally asymptotically stable equilibrium given as follows:
(1) X0,∅, if R
n
0 ≤ 1;
(2) X1,∅, if 1 < R
1
0, and P
1
0 ≤ 1.
(3) If P 10 > 1, let J be the maximal antigenic set. Then
(a) If J is a stable antigenic set, then the equilibrium X0,J is globally asymptotically
stable.
(b) Otherwise, let j′ be the smallest integer such that j′ 6∈ J , which exists by virtue
of Lemma 1. Then the equilibrium Xj′,J is globally asymptotically stable.
Proof of Theorem 1. Following Korobeinikov (2004a), we shall use the following Lyapunov
function:
V (x,y,v, z) = x− x∗ ln(x/x∗) +
n∑
i=1
(yi − y
∗
i ln(yi/y
∗
i ))+
+
n∑
i=1
Ci (vi − v
∗
i ln(vi/v
∗
i )) + p
n∑
i=1
1
ci
(zi − z
∗
i ln(zi/z
∗)) ,
GLOBAL STABILITY FOR A CLASS OF VIRUS MODELS 9
where Ci will be a constant to be specified later on.
Then, using the uniform notation of the the equilibria of (6), that is set in Lemma 2, see
§3.1, we have that
V˙ =
d
dt
V (x(t),y(t),v(t), z(t))
λ
[
+Qxj,J +
n∑
i=1
Qyij,J +
d
λ
n∑
i=1
Ci
ui
βi
Qvij,J +
n∑
i=1
Qzij,J
Ii0
]
−
[
dx+
λ2Qxj,J
dx
]
−
− λ
n∑
i=1
βi
ai
Qyij,J
xvi
yi
− dk
n∑
i=1
Ci
βi
Qvij,J
yi
vi
+
n∑
i=1
yi
[
kCi − ai − aiQ
zi
j,J
]
+(10)
λ
d
Qxj,J
n∑
i=1
viβi −
n∑
i=1
Ciuivi + pλ
n∑
i=1
aizi
[
Qyij,J −
1
Ii0
]
.
For the first two equilibria, we consider the Lyapunov function (10), with Ci = ai/k. Then,
on using the structure of equilibria of (6), we may write V˙ as follows:
V˙ =λ
[
1 +Qxj,J +
n∑
i=1
Qyij,J +
n∑
i=1
Qvij,J
Ri0
+
n∑
i=1
Qzij,J
Ii0
]
−
[
dx+
λ2Qxj,J
dx
]
−
− λ
n∑
i=1
βi
ai
Qyij,J
xvi
yi
− d
n∑
i=1
ai
βi
Qvij,J
yi
vi
−
n∑
i=1
aiQ
zi
j,J yi+
+
λ
d
n∑
i=1
βivi
[
Qxj,J −
1
Ri0
]
+ pλ
n∑
i=1
zi
ai
[
Qyij,J −
1
Ii0
]
.
For X0,∅, we find, using Lemma 2, that
V˙ = 2λ−
[
dx+
λ2
dx
]
+
λ
d
n∑
i=1
βivi
[
1−
1
Ri0
]
− pλ
n∑
i=1
zi
aiI
i
0
.
Since Ri0 ≤ 1, for i = 1, . . . , n, and
dx+
λ2
dx
≥ 2λ,
we have that V˙ < 0 in O+. Hence, that X0,∅ is globally asymptotically stable in this case.
Now, suppose that 1 < R10, and that P
1
0 ≤ 1. In this case, Lemma 2 yields that
V˙ =λ
[
3
(
−
1
R10
)
+
2
R10
]
−
[
dx+
λ2
R10dx
]
−
λ
a1
β1
(
1−
1
R10
)
xv1
y1
−
a1d
β1
(R10 − 1)
y1
v1
+
+
λ
d
n∑
i=1
βivi
[
1
R10
−
1
Ri0
]
+ pλ
z1
a1
[
1−
1
R10
−
1
I10
]
− pλ
n∑
i=2
zi
aiI
i
0
.
The last term in V˙ is clearly negative. We also observe that, since Ri0 < R
1
0, for 1 < i ≤ n,
we have that
n∑
i=1
βivi
[
1
R10
−
1
Ri0
]
< 0.
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Also, since P 10 ≤ 1, then we have that R
1
0 ≤ 1+R
1
0/I
1
0 . Therefore, the last three terms in the
expression for V˙ are negative.
For the remaining terms, let us write
λ2
R10
=
(
λ
R10
)2
+
(
1−
1
R10
)
λ2
R10
.
Then we have that
dx+
(
λ2
R10dx
)2
≥ 2
λ
R10
,
and that
.
λ2
R10dx
(
1−
1
R10
)
+ λ
β1
a1
(
1−
1
R10
)
xv1
y1
+
da1
β1
(R10 − 1)
y1
v1
≥ 3λ
(
1−
1
R10
)
.
Thus V˙ < 0 inO+, and hence we have thatX1,∅ is a globally asymptotically stable equilibrium.
Finally, if P 10 > 1, then let J be the maximal antigenic set. First, we assume that J is
stable antigenic and show that X0,J is globally asymptotically stable. In this case, we use
the Lyapunov function (10), with Ci = x
∗βi/ui.
Using Lemma 2, this can be further recast as V˙ = V˙1 + V˙2, where
V˙1 =λ
[
3−
1
1 + ρJ0
]
−
[
dx+
λ2
dx
(
1 + ρJ0
)
]
− λ
∑
i∈J
βi
Ii0ai
xvi
yi
−
λk
1 + ρJ0
∑
i∈J
Ri0
uiIi0
yi
vi
;
V˙2 =
∑
i 6∈J
aiyi
[
Ri0
1 + ρJ0
− 1
]
− pλ
∑
i 6∈J
zi
aiIi0
.
We treat V˙2 first. The last term is clearly negative. Also, since for i 6∈ J , we have that
Ri0
1 + ρJ0
< 1 and thus that
∑
i 6∈J
yi
[
Ri0
1 + ρJ0
− 1
]
< 0.
Therefore, V˙2 < 0, when J 6= N .
Let
η =
ρJ0
1 + ρJ0
and ηi =
Ri
0
Ii
0
1 + ρJ0
, i ∈ J .
Then, we may write V˙1 as
V˙1 = λ

3− 1
1 +
ρJ
0
I0

−
[
dx+
λ2
dx
(
1 + ρJ0
)2
]
−
−
∑
i∈J
λ2ηi
dx
(
1 + ρJ0
) − λ∑
i∈J
βi
Ii0ai
xvi
yi
−
λk
1 + ρJ0
∑
i∈J
Ri0
uiI
i
0
yi
vi
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For each i ∈ J , we have
−
λ2
Ri
0
Ii
0
dx
(
1 + ρJ0
)2 − λ βiIi0ai
xvi
yi
−
λk
1 + ρJ0
Ri0
uiIi0
yi
vi
≤ −3λ

 R
i
0
Ii
0
1 + ρJ0

 ,
and that
dx+
λ2
dx
(
1 + ρJ0
)2 > 2λ 11 + ρJ0 .
After combining these estimates and summing for i ∈ J , we get that V˙1 ≤ 0 and thus we
have the result, If J is a proper subset of N . In the case that J = N , we have V˙ ≤ 0, with
equality ocurring only when
x =
λ
d
Qx0,J and
vi
yi
=
ki
ui
.
Inasmuch this plane is not invariant by the corresponding flow—other than the point X0,J—
we have global stability as a consequence of LaSalle’s theorem (LaSalle 1964). For the fourth
point, we use a mix of the two Lyapunov functions above, namely:
V (x,y,v, z) =x− x∗ ln(x/x∗) +
n∑
i=1
(yi − y
∗
i ln(yi/y
∗
i ))+
+ x∗
n∑
i=1
i6=j′
βi
ui
(vi − v
∗
i ln(vi/v
∗
i )) + p
n∑
i=1
1
ci
(zi − z
∗
i ln(zi/z
∗))+
+
aj′
k
(
vj′ − v
∗
j′ ln(vj′/v
∗
j′)
)
.
Computing V˙ and using the uniform notation, we find that
V˙ =λ

1 +Qxj′,J +
n∑
i=1
Qyij′,J +Q
x
j′,J
n∑
i=1
i6=j′
Qvij′,J +
n∑
i=1
Qzij′,J
Ii0
+
Q
vj′
j′,J
Rj
′
0

−
[
dx+
λ2Qxj′,J
dx
]
−
− λ
n∑
i=1
βiQ
yi
j′,J
ai
xvi
yi
− λkQxj′,J
n∑
i=1
i6=j′
Qvij′,J
ui
yi
vi
+
n∑
i=1
i6=j′
yi
[
βiλk
dui
Qxj′,J − ai − aiQ
zi
j′,J
]
+
+ pλ
n∑
i=1
zi
ai
[
Qyij′,J −
1
Ii0
]
−
daj′
βj′
Q
vj′
j′,J
yj′
vj′
− aj′Q
zj′
j′,J yj′ +
λβj′
d
vj′
[
Qxj′,J −
1
Rj
′
0
]
On using Lemma 2, and that
1 =
(
1−
1
Rj
′
0
−
ρJ0
Rj
′
0
)
+
1
Rj
′
0
+
ρJ0
Rj
′
0
,
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where each term in the sum is positive, but smaller than one, we rewrite it as V˙ = V˙1 + V˙2 +
V˙3 + V˙4, where
V˙1 =
(
1−
1
Rj
′
0
−
ρJ0
Rj
′
0
)[
3λ−
λ2
dxRj
′
0
−
λβj′
aj′
xvj′
yj′
−
daj′R
j′
0
βj′
yj′
vj′
]
,
V˙2 =
2λ
Rj
′
0
−
[
dx+
λ2
dx(Rj
′
0 )
2
]
,
V˙3 = 3λ
ρJ0
Rj
′
0
−
λ2ρJ0
dx(Rj
′
0 )
2
− λ
∑
i∈J
βi
aiI
i
0
xvi
yi
−
λk
Rj
′
0
∑
i∈J
Ri0
uiI
i
0
yi
vi
,
V˙4 =
pλzj′
aj′
(
1−
1
Rj
′
0
−
ρJ0
Rj
′
0
−
1
Ij
′
0
)
.
The terms V˙1, V˙2 and V˙3 can be treated similarly as in the previous equilibria and are all
nonpositive in the interior.
As for V˙4, first we observe that
1−
1
Rj
′
0
−
ρJ0
Rj
′
0
−
1
Ij
′
0
=
1
Rj
′
0
(
Rj
′
0 − 1− ρ
J
0 −
Rj
′
0
Ij
′
0
)
if j′ 6∈ S, then we that
Rj
′
0 − 1− ρ
J
0 −
Rj
′
0
Ij
′
0
< Rj
′
0 − 1−
Rj
′
0
Ij
′
0
≤ 0.
If j′ ∈ S, then let J ′ = J ∪ {j′}. Then we have that
1−
1
Rj
′
0
−
ρJ0
Rj
′
0
−
1
Ij
′
0
=
1
Rj
′
0
(
Rj
′
0 − 1− ρ
J ′
0
)
.
Since J is the maximal antigenic set, we must have that
Rj
′
0 − 1− ρ
J ′
0 ≤ 0.

3.3. Nonunique Fitness. Given the non-generic nature of this case, we shall only briefly
discuss the stability when some of the strains have the same fitness, i.e., there exists at lest
one index set Γ, such that Ri0 = R
j
0, for i, j ∈ Γ. Notice that, in this case, we have non-isolated
equilibria.
We start by observing that the computation with the Lyapunov function for the equilibrium
X0,∅ does not depend on the uniqueness of fitness. Hence we have
Corollary 1. If Ri0 ≤ 1, for i = 1, . . . , n, then X0,∅ is a globally asymptotically stable equi-
librium.
The case Ii0 = I0, 1 < R
1
0 and P
1
0 < 1 can also be partially treated:
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Proposition 1. Let Γ be the set of indices i ∈ N such that Ri0 = R
n
0 . Let EΓ be the set
satisfying
x∗ =
λ
dRn0
, yj = vj = 0, j 6∈ Γ,
∑
j∈Γ
βjvj =
dx∗ − λ
x∗
, vj ≥ 0,
vi =
k
u
yi, and zi = 0, i ∈ N .
If x(t,x0) is a solution of (4), with initial condition x0, then
x(t)→ EΓ, as t→∞.
Proof. Let us denote the omega set of x(t,x0) by Ω(x0). As shown in (Pastore 2005), the
solutions to (4) are bounded in R3n+1+ . Hence, Ω(x0) is compact.
Using the same Lyapunov function for X1,∅ as in Section 3.2, we find that
V˙ =λ
[
3−
1
R10
]
−
[
dx+
λ2
R10dx
]
−
λ
a
β1
(
1−
1
R10
)
xv1
y1
−
ad
β1
(R10 − 1)
y1
v1
+
+
λ
d
∑
i 6∈Γ
βivi
[
1
R10
−
1
Ri0
]
+
pλ
a
n∑
i=1
zi
[
1−
1
Ri0
−
1
I0
]
.
The same calculations in section 3.2 shows that V˙ ≤ 0. However, notice that V˙ = 0 in EΓ. If
s ∈ RN and S ⊂ RN is closed, then let
d(s, S) = min
s′∈S
‖s− s′‖.
LaSalle’s invariant principle then yields that,
lim
t→∞
d(x(t), EΓ) = 0.

Corollary 2. If R10 > R
i
0 for i = 2, . . . , n, then X1,∅ is a globally asymptotically stable
equilibrium, when 1 < R10 ≤ 1 +R
1
0/I0.
We have performed numerical calculations of (4), using a high order Runge-Kutta method,
which suggest that in the case treated by proposition 1, a solution of System (4) will converge
to a unique equilibrium point in EΓ, that depends only on the initial condition.
Finally, when the viable set of strains is not the full antigenic variation, we have
Proposition 2. If Ii0 = I0, P
1
0 > 1. Assume that J 6= I is a stable antigenic set, then we
have that X0,J is a globally asymptotic stable equilibrium.
Proof. In this case, the estimate V˙1 ≤ 0 remains valid. Moreover, if J 6= I, then we must
have V˙2 < 0, which yields the result. 
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4. Conclusions
In this work, we have performed a thorough study of System (4). As a preliminary result,
we have shown that, when the both the virus production rate and the CTL interaction
rate are nonzero for all strains, then System (4) is dynamically equivalent to System (6),
which has strain-independent virus production and CTL interaction rates. In particular, the
precise nonzero values of the CTL interaction rates are completely irrelevant to the dynamical
behaviour of the system. This seems to suggest that a more refined model which is able to
capture this difference is needed.
We have also identified all the 2n−1(2 + n) equilibria of (6) in Lemma 2. When n is
large this can be quite a large number. Nevertheless, under the hypothesis of unique fitness,
we were able to show that only four of them are dynamically relevant. More precisely, we
assume that the virus basic reproduction rates, Ri0 are distinct and that the CTL reproduction
numbers, P i0 have the same ordering as the R
i
0. This last condition is automatically satisfied
if Ii0 = I0 for all i. In this case, Theorem 1 shows that, if the largest reproduction number,
R10, is smaller than one, the the disease-free equilibrium—X0,∅ in the notation of Lemma 2—is
globally asymptotic stable. In this case, no strain is viable and the infection dies out. On
the other hand, if R10 > 1, but P
1
0 < 1, then only the first strain survives, and the infection
persists. If P 10 > 1, then we have that the two outcomes are possible: either a (unique)
stable antigenic set exists and then X0,J is globally asymptotic stable. In this case, the set
J determines the antigenic diversity. In other words, a strong immune response generates a
larger antigenic variation. Alternatively, there exits a pair (j′,J ) such that the point Xj′,J is
globally asymptotic stable. In this case, the strain with the weakest fitness will not actually
trigger the CTL response at all in the long run. In the case of absence of antigenic variation,
i.e. System (3), then only the first outcome is possible. We were unable to interpret in a
biological sense the combinatorial conditions of existence of a stable antigenic set, and we
believe that this should be addressed in the future. The results presented in Theorem 1 show
rigorously some of the inferences that have already been made in Nowak & Bangham (1996)
based on extensive simulations of System (4).
We have also shown some results for very special cases in which the Ri0s are not distinct.
In these cases, the equilibria is not isolated and this complicates the matters further. Also,
we have not addressed that case when the set of strong responders is not consistent, and this
might also merit further study in the future.
References
B. Asquith & C. R. M. Bangham (2003). ‘An introduction to lymphocyte and viral dynamics: the power
and limitations of mathematical analysis’. Proceedings of The Royal Society of London Series B-Biological
Sciences 270(1525):1651–1657.
G. A. Bocharov & A. A. Romanyukha (1994). ‘Mathematical-Model of Antiviral Immune-Response-Iii -
Influenza-A Virus-Infection’. Journal of Theoretical Biology 167(4):323–360.
GLOBAL STABILITY FOR A CLASS OF VIRUS MODELS 15
S. Bonhoeffer, et al. (1997). ‘Virus Dynamics and Drug Therapy’. Proc. Natl. Acad. Sci. USA 94:6971–6974.
P. de Leenheer & H. L. Smith (2003). ‘Virus Dynamics: a Global Analysis’. SIAM J. Appl. Math. 63:1313–1327.
B. Kooi, et al. (1998). ‘On the Use of the Logistic Equation in Models of Food Chains’. Bull. Math. Biol.
60:231–246.
B. Kooi & P. Hanegraaf (2001). ‘Bi-trophic Food Chain Dynamics with Multiple Component Populations’.
Bull. Math. Biol. 63(2):271–299.
A. Korebeinikov & G. C. Wake (1999). ‘Global properties of three-dimensional predator-prey models’. Journal
of Applied Mathematics & Decision Sciences 3(2):155–162.
A. Korobeinikov (2004a). ‘Global Properties of Basic Virus Dynamics Models’. Bull. Math. Biol. 66:879–883.
A. Korobeinikov (2004b). ‘Lyapunov functions and global properties for SEIR and SEIS epidemic models’.
Math. Med. Biol. 21(2):75–83.
J. P. LaSalle (1964). ‘Recent advances in Liapunov stability theory’. SIAM Rev. 6:1–11.
M. Y. Li & J. S. Muldowney (1995). ‘Global Stability For The Seir Model In Epidemiology’. Mathematical
Biosciences 125(2):155–164.
G. I. Marchuk, et al. (1991). ‘Mathematical-Model Of Antiviral Immune-Response .2. Parameters Identification
For Acute Viral Hepatitis-B’. Journal Of Theoretical Biology 151(1):41–70.
A. U. Neumann, et al. (1998). ‘Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha
therapy’. Science 282(5386):103–107.
M. A. Nowak & C. R. M. Bangham (1996). ‘Population Dynamics of Immune Responses to Persitent Viruses’.
Science 272:74–79.
M. A. Nowak & R. M. May (2000). Virus Dynamics: Mathematical Principles of Immunology and Virology.
Oxford University Press.
D. H. Pastore (2005). A Dinaˆmica no Sistema Imunolo´gico na Presenc¸a de Mutac¸a˜o. Ph.D. thesis, IMPA.
A. S. Perelson, et al. (1993). ‘Dynamics Of Hiv-Infection Of Cd4+ T-Cells’. Mathematical Biosciences
114(1):81–125.
A. S. Perelson & P. W. Nelson (1999). ‘Mathematical analysis of HIV-1 dynamics in vivo’. SIAM Review
41:3–44.
A. S. Perelson, et al. (1996). ‘HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral
generation time’. Science 271(5255):1582–1586.
A. B. Roy & F. Solimano (1986). ‘Global stability of partially closed food-chains with resources’. Bull. Math.
Biol. 48(5-6):455–468.
H. L. Smith (1995). Monotone Dynamical Systems. AMS.
Departamento de Matema´tica Aplicada, Universidade Federal Fluminense, R. Ma´rio Santos
Braga, s/n, Nitero´i, RJ 22240-120, Brazil.
E-mail address: msouza@mat.uff.br
IMPA, Est. D. Castorina 110, Rio de Janeiro, RJ 22460-320, Brazil
E-mail address: zubelli@impa.br
